MedWatch

Innovation Fund joins European personalized medicine project

The development of personalized medicine in Europe will be reinforced through a new collaborative effort, with Innovation Fund Denmark coordinating the effort in Denmark and pitching in financially.

Foto: Lundbeck/PR

“Why don’t we see a breakthrough in personalized medicine? When you look at the reports in Nature Reviews Drug Discovery from recent years, the bulk of the projects in phase II or III have a biomarker that allows you to select patients who benefit from the drugs. Why don’t we see a shift in the market? What does it take before we see a breakthrough?”

Those hypothetical questions where posed by Peter Høngaard Andersen, managing director of Innovation Fund Denmark, when MedWatch asked him what he would really like to ask other players in the life science industry, as part of our summer series.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier